Biodexa Pharmaceuticals annual gross margin
2015
2016
2017
Biodexa Pharmaceuticals Gross Margin Growth & History (BDRX)
Biodexa Pharmaceuticals's gross margin was 674.62% for fiscal 2017.
View full Biodexa Pharmaceuticals company overviewBiodexa Pharmaceuticals annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2017 | 2017-12-31 | 674.62% | +201.76 pp |
| 2016 | 2016-12-31 | 472.86% | +377.96 pp |
| 2015 | 2015-12-31 | 94.91% | — |
Biodexa Pharmaceuticals quarterly gross margin
No reported data
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|
Biodexa Pharmaceuticals gross margin trends
Across the available reported history, Biodexa Pharmaceuticals's gross margin increased from 472.86% to 674.62%, a change of +201.76 percentage points.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Biodexa Pharmaceuticals filings at SEC.gov ↗